Ram Kumar Rastogi, MD | |
7575 Ritchie Hwy, Glen Burnie, MD 21061-8951 | |
(410) 766-1444 | |
(410) 766-9453 |
Full Name | Ram Kumar Rastogi |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7575 Ritchie Hwy, Glen Burnie, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801897350 | NPI | - | NPPES |
34811001 | Other | MD | BSMD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | D0017737 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ram Kumar Rastogi, MD 7575 Ritchie Hwy, Glen Burnie, MD 21061-8951 Ph: (410) 766-1444 | Ram Kumar Rastogi, MD 7575 Ritchie Hwy, Glen Burnie, MD 21061-8951 Ph: (410) 766-1444 |
News Archive
A unique Beta 1,3-1,6 Glucan based Japanese health supplement, produced by black yeast, Aureobasidium Pullulans, could strategically help tackle Covid-19 in people with comorbid conditions like diabetes, kidney and heart diseases, as published in Frontiers in Immunology Journal recommending clinical studies, for validation.
The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.
Researchers in the biomedical engineering department at Case Western Reserve University have found that epileptic activity can spread through a part of the brain in a new way, suggesting a possible novel target for seizure-blocking medicines.
Value in Health, the official journal of ISPOR-;the professional society for health economics and outcomes research, announced today the publication of results of a study suggesting that time-driven activity-based costing can be an effective technique to support value-based healthcare initiatives.
Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
› Verified 3 days ago
Dr. James Stonewall Dorsey, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N, Suite B, Glen Burnie, MD 21060 Phone: 410-222-0100 | |
N'dama M Bamba, General Practice Medicare: Medicare Enrolled Practice Location: 1406b Crain Hwy S Ste 308, Glen Burnie, MD 21061 Phone: 443-952-8255 |